创胜集团 - 全整合型国际化生物制药公司

创胜集团, 生物药, 抗体, 药物研发

创胜集团 - 全整合型国际化生物制药公司

加入我们 联系我们

媒体报道

媒体报道

Industrialization of Highly Intensified Connected/Continuous Biomanufacturing Platform (HiCB) to Address Patient and Business Needs

2022 年 11 月 25 日

- Integrate HiCB and novel facility design to provide flexibility, speed, high quality at low cost  

- Platform designed to simplified PD while minimizing tech transfer, scale up and manufacturing risks

- Showcase implementation strategy and plan